SARS-CoV-2 Serological Studies around the World

Dear Colleagues,

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for COVID-19, a severe pneumonia leading to respiratory distress, has now spread around the world with more than 615 million people being infected.

During the course of the pandemic, several variants carrying amino acid changes in the entire genome of SARS-CoV-2 emerged worldwide. The emergence of these variants was often accompanied by a loss of effectiveness of immune efficiency, induced by primary infection, vaccination or therapeutic treatments.

The need for serological investigation to analyze the antibody responses, titer and duration elicited by primary infection or vaccination against the circulating variants will greatly help the identification of the populations at risk of re-infection and will help monitor the efficacy of COVID-19 vaccines, thus, accelerating the public health policy decision.

For this Special Issue, both reviews and research articles describing the SARS-CoV-2 sero-epidemiology using robust system or gold standard tools will be welcome.  

Dr. Julien Mélade
Dr. Paola Mariela Saba Villarroel
Prof. Dr. François Meurens
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.